21.90NOK+4.29%Mkt Cap: —P/E: 23.351d ago
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp a…
Industry Peers
Healthcare$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$375.50BUSDP/E 122.7
$341.92BUSDP/E 24.5
$348.81BUSDP/E 25.0
$279.13BUSDP/E 22.3
$274.07BUSDP/E 23.6
$240.45BUSDP/E 24.5
$231.49BUSDP/E 24.5
$238.75BUSDP/E 27.4
$226.85BUSDP/E 33.1
$190.75BUSDP/E 11.3
$198.81BUSDP/E 36.9
$183.02BUSD
$160.96BUSDP/E 37.2
$151.78BUSDP/E 38.6
$142.49BUSDP/E 45.6
$139.84BUSDP/E 32.2
$138.11BUSDP/E 14.9
Key Statistics
Company
Market Cap—
Enterprise Value70.44M $
Revenue (TTM)12.00M $
Gross Profit11.43M $
Net Income (TTM)1.26M $
Revenue/Share0.2275 USD
Last Price21.90 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees50
CountryGB
SectorHealthcare
Industry—
ISINNO0010014632
Valuation
P/E (Trailing)23.35
P/E (Forward)—
PEG—
EV/EBITDA64.16
EV/Revenue5.87
P/S—
P/B3.06
EPS (TTM)0.94
EPS (Forward)—
52W Range
20.30100% of range21.90
52W High21.90 NOK
52W Low20.30 NOK
Profitability
Gross Margin95.22%
Oper. Margin-2.15%
EBITDA Margin9.15%
Profit Margin10.46%
ROE4.05%
ROA1.37%
Growth
Revenue Growth40.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.48M $
CapEx (TTM)—
FCF Margin10.68%
FCF Yield—
Net Debt-22.90M $
Net Debt/EBITDA-20.85
Balance Sheet
Debt/Equity5.63
Current Ratio15.83
Quick Ratio14.80
Book Value/Sh6.625 NOK
Cash/Share5.171 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float42.19M
Insiders17.41%
Institutions14.23%
Technical
SMA 5038.40 (-43.0%)
SMA 20036.55 (-40.1%)
Beta0.56
S&P 52W Chg20.80%
Avg Vol (30d)368
Avg Vol (10d)1.01K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—